BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 29, 2004
View Archived Issues
IRA-01 shows fair antiarthritic effect, good safety and favorable lipid profile
Read More
SGN-15 and docetaxel combination promising in non-small cell lung cancer
Read More
Licofelone in symptomatic OA of the knee
Read More
Statins a potential therapeutic option in glaucoma
Read More
Vertex scientists prepare and test new inhibitors of JAK, JNK, CDK, etc.
Read More
Novel LTD4 antagonists and their use reported by Almirall Prodesfarma
Read More
Two series of MEK/c-Src kinase inhibitors claimed by AstraZeneca
Read More
New histamine H3 receptor ligands and their use claimed by Abbott
Read More
Oral PTH enters phase I trial under Unigene/GSK collaboration
Read More
IND accepted for phase II trials of Aplidin
Read More
New phase II trial of MDX-070 in hormone refractory prostate cancer
Read More
Millennium reacquires Integrilin European rights, licenses to GSK
Read More
Target enrollment met in phase III study of Campath for B-CLL
Read More
Closing date of Sanofi-Synthelabo's offer on Aventis postponed to July 30, 2004
Read More
Phase IIb trial of tgAAVCF for cystic fibrosis cleared to continue
Read More
XL-119 enters phase III trial in bile duct cancer
Read More
Change of indications for phase II trials of KOS-862
Read More
Singapore study for Dynavax HBV prophylactic vaccine
Read More
Sigma-Tau plans phase II European trial of TB4 for venous stasis ulcers
Read More
RI-624 enters phase I testing for pain
Read More
Positive interim results from phase I study of Davanat-1
Read More
Antiinflammatory and cardiovascular benefits found with atorvastatin in rheumatoid arthritis
Read More
Add-on therapy with safinamide improves motor function in Parkinson's disease
Read More
Therapeutic benefits of adjunctive istradefylline in advanced Parkinson's disease
Read More
French team prepares and tests a novel antithrombotic agent
Read More
Cyclacel claims new CDK inhibitors for cancer and viral infections
Read More
Repinotan study results reported at World Stroke Congress
Read More
Study parameters affect preclinical outcomes with neuroprotective agents
Read More
Study suggests simvastatin can prevent silent brain infarct
Read More